Abstract: There is a need for more effective and efficient text categorization. This need can be addressed by, for example, techniques for semantic text categorization. In one example, a method includes determining an input vector-based representation of an input document; processing the input vector-based representation using a trained supervised machine learning model to generate the categorization based at least in part on the input vector-based representation, wherein: (i) the trained supervised machine learning model has been trained using automatically-generated training data, and (ii) the automatically generated training data is generated by determining an inferred semantic label for each unlabeled training document of one or more unlabeled training documents; and performing one or more categorization-based actions based at least in part on the categorization, and (iii) the labels are described by one or more short documents/short texts.

Abstract: The invention provides an engineered carboxylic acid reductase (CAR) enzyme, a nucleic acid encoding the CAR enzyme, and a non-naturally occurring microbial organism comprising an exogenous nucleic acid encoding the CAR, an engineered transaminase (TA) enzyme, and/or a hexamethylenediamine (HMD) transaminase (TA2) enzyme. The invention provides a non-naturally occurring microbial organism that has a 1,6-hexanediol (HDO) pathway with a HDO pathway enzyme expressed in sufficient amounts to produce 6 aminocaproate semialdehyde, HDO, or both. The invention further provides a non-naturally occurring microbial organism that has an HMD pathway with a HMD pathway enzyme expressed in sufficient amounts to produce 6-aminocaproate semialdehyde, HMD, or both. The invention additionally provides bioderived HMD, 6-aminocaproate semialdehyde, and/or HDO and methods for producing bioderived HMD, 6-aminocaproate semialdehyde, and/or HDO.

Abstract: The disclosure provides pharmaceutical compositions comprising an anti-PD-1 antibody or an anti-PD-L1 antibody. In some aspects, the pharmaceutical compositions are formulated for subcutaneous delivery. In some aspects, the pharmaceutical compositions further comprise an endoglycosidase hydrolase enzyme. Other aspects of the present disclosure are directed to methods of subcutaneously delivering a pharmaceutical composition comprising an anti-PD-1 antibody or an anti-PD-L1 antibody.

Abstract: The present invention discloses an integrated system (100) within the online social networking platforms (101), designed to ensure authenticity and amplify user engagement. The system (100) orchestrates the enabling of users to upload both avatar and real images, linked to their profiles, thus giving rise to bona fide visual identities. Facilitated by a user-friendly interface (103), the system (100) provides effortless transitions between avatar and real profile images, thereby enriching engagement encounters. The assurance of controlled access to authentic image profiles is administered through a permission management module (105). Moreover, the system employs placeholder notifications to gently guide users in aligning their visual identities, thus fostering an environment that embodies authenticity, security, and heightened engagement within the online social networking realm.

Abstract: The disclosed invention relates to a commenting entitlement system (100) within an online social networking platform (101), leveraging real-ID verification for enhanced user interactions. The system (100) comprises a real ID setup module (102) that streamlines real-ID verification during user registration, fortifying identity authenticity. Furthermore, the system (100) incorporates a commenting module (103) permitting users with verified real IDs to engage in diverse interaction activities on the online social networking platform (101). Additionally, a user ‘hash’ generation module (104) is integrated, producing a distinct user ‘hash’ that anonymously correlates real IDs with corresponding user profiles, ensuring confidential connections and a multi-account prevention module (105) is integrated, constraining engagement across multiple accounts using identical real ID-based user ‘hashes.

Abstract: The present invention discloses an integrated anti-trolling and content moderation system (100) for an online platform that pioneers a transformative approach to a digital interaction. Through a Troll Detection Module (102), offensive content is thwarted at its source, while a Personalized Moderation Module (103) empowers the user to nominate moderators for pre-publication assessment, fostering transparency and accountability. Augmenting user communication, an AI-driven Suggestions Module (104) provides the user with alternative rephrasing suggestions before posting, fostering the promotion of polite and constructive communication. The system incorporates a Collaborative Moderation Module (105), enabling the collective assessment of a content by multiple moderators. A user profile management Module (106) diligently tracks and showcases true positive trolling instances, accompanied by temporary commenting restrictions following the identification of trolling behavior.

Abstract: The present invention discloses a system (100) for direct content monetization through a Non-Fungible Token (NFT) on a social networking platform (101). Users are provided with a Content Creation Module (102) that empowers them to generate diverse digital content. A Conversion Module (103) transforms user-generated content into valuable NFTs. A Display Module (104) seamlessly integrates NFTs into the platform's interface, enhancing content visibility. An Economic Transaction Module (105) enables various economic transactions involving NFTs. A Payment Processing Module (106) offers flexible payment options, including cryptocurrencies and fiat currency. The system harnesses blockchain technology (107) to ensure transparent and secure recording of NFT ownership and transactions. Together, these components redefine content monetization, bridging the gap between creators and their audiences, and creating a unified platform for content creators to realize the full potential of their creations.

Abstract: A system (100) for evaluating user demeanor and authenticity comprises a profile ring feature module (102) configured to exhibit a profile ring on a profile of each user, wherein the profile ring serves as an indicator within an online social networking platform (101), a user activity tracking module (103) configured to generate one or more signals derived from a plurality of actions executed by users on the online social networking platform (101), a notification module (104) configured to provide real time notifications to the user upon detecting variations in the color of the profile ring, Further, the present invention discloses a method (200) that generates valuable data about user engagement patterns and behavior. This data is analyzed over time to derive insights into user trends, preferences, and interactions, aiding in platform improvement and strategic decision-making.

Abstract: The Collaborative Non-Fungible Token Advertising System (100) for Targeted Influence on Social Network introduces a novel approach where brands collaborate with influencers (102) to co-create NFTs featuring brand-related contents (103). The NFTs are strategically displayed to influencer networks (104), leveraging credibility and engagement for effective advertising. Through secure blockchain technology (107) and interactive interfaces, the system (100) optimizes revenue generation (105) and revenue sharing (106), user interaction, and authenticity, thereby revolutionizing advertising dynamics within social networks.

Abstract: The disclosure provides pharmaceutical compositions comprising an anti-PD-1 antibody or an anti-PD-L1 antibody. In some aspects, the pharmaceutical compositions are formulated for subcutaneous delivery. In some aspects, the pharmaceutical compositions further comprise an endoglycosidase hydrolase enzyme. Other aspects of the present disclosure are directed to methods of subcutaneously delivering a pharmaceutical composition comprising an anti-PD-1 antibody or an anti-PD-L1 antibody.

Abstract: The disclosure provides pharmaceutical compositions comprising an antibody and at least two antioxidants. In some aspects, pharmaceutical composition is formulated for subcutaneous delivery. In some aspects, the pharmaceutical composition further comprises an endoglycosidase hydrolase enzyme. Other aspects of the present disclosure are directed to methods of subcutaneously delivering the pharmaceutical composition.

Abstract: A formation method is provided. During this formation method, a metallic substrate is provided. A coating is deposited onto the metallic substrate using a suspension plasma spray process. The coating is formed from or otherwise includes copper oxide.

Abstract: Disclosed is an approach to implement an architecture and methodology that allows rapid access to provisioned software without requiring the entirety of the software distribution to be transferred to the target system in an upfront manner. Instead, a multi-tier architecture is used that allows the software to be provisioned and accessed with efficient access and reads of distribution materials from one or more remote storage locations.

Abstract: Disclosed is an approach to implement an architecture and methodology that allows rapid access to provisioned software without requiring the entirety of the software distribution to be transferred to the target system in an upfront manner. Instead, a multi-tier architecture is used that allows the software to be provisioned and accessed with efficient access and reads of distribution materials from one or more remote storage locations.

Abstract: The disclosure provides pharmaceutical compositions comprising an anti-PD-1 antibody or an anti-PD-L1 antibody. In some aspects, the pharmaceutical compositions are formulated for subcutaneous delivery. In some aspects, the pharmaceutical compositions further comprise an endoglycosidase hydrolase enzyme. Other aspects of the present disclosure are directed to methods of subcutaneously delivering a pharmaceutical composition comprising an anti-PD-1 antibody or an anti-PD-L1 antibody.

Abstract: The disclosure provides pharmaceutical compositions comprising an antibody and at least two antioxidants. In some aspects, pharmaceutical composition is formulated for subcutaneous delivery. In some aspects, the pharmaceutical composition further comprises an endoglycosidase hydrolase enzyme. Other aspects of the present disclosure are directed to methods of subcutaneously delivering the pharmaceutical composition.

Abstract: Techniques are provided for transitioning from a hierarchical file system to an object store. A request is received to change file metadata of a hierarchical file system. In response to the request: in-cache file metadata of the hierarchical file system is modified. The in-cache file metadata includes a directory structure of the hierarchical file system and file metadata of the hierarchical file system. Additionally, an in-store metadata journal entry is generated. The in-store metadata journal entry indicates an update to in-store file metadata. The in-store file metadata includes the directory structure of the hierarchical file system and file metadata of the hierarchical file system and is stored in an object store. The in-store metadata journal entry is stored in the object store. Furthermore, in-store file metadata and in-store metadata journal entry may be used to reconstruct the in-cache file metadata on another node.

Abstract: Systems and methods are described for providing subtitles based on a user's language proficiency. An illustrative method includes receiving a request to display subtitles, selecting a language for the subtitles, determining, from a user profile, a user's proficiency level in the selected language, selecting, based on the user's proficiency level in the selected language, a set of subtitles from a plurality of sets of subtitles in the selected language, wherein each respective set of subtitles corresponds to a different proficiency level in the selected language, and generating for display the selected set of subtitles.

Abstract: A method, computer program product, and computing system for determining, at the computing device, one or more dependencies associated with a plurality of managed objects and a plurality of backend objects. One or more backend notifications associated with one or more backend objects of the plurality of backend objects may be received. One or more managed objects of the plurality of managed objects associated with the one or more backend objects of the one or more backend notifications may be identified, based upon, at least in part, the one or more dependencies associated with the plurality of managed objects and the plurality of backend objects. The one or more identified managed objects of the plurality of managed objects may be updated based upon, at least in part, the one or more backend notifications.

Abstract: Systems and methods are described for providing subtitles based on a user's language proficiency.